Admetsys Corporation products

Provides automated extracorporeal whole-blood biosensing with zero blood loss to the patient. Cartridge-based design with 4 analytes: blood glucose, lactate, temperature, hematocrit (expandable to 20 analytes), providing up to 7 days of continuous biosensing. Enables early detection and mitigation of sepsis, informs PrecisionOne`s glucose regulation function.

Captures data from one or more biosensors. Constructs an evolving computational (AI) model of each patient`s metabolism in real time. Autonomously regulates patient glucose with zero clinician intervention, directly infusing continuously-optimized insulin and dextrose therapy.